NCT05111288Recruiting
Influence of Pulse Electromagnetic Field Therapy on Myocardial Ischemia
Source: ClinicalTrials.gov · Last updated 9 Sept 2026
Brief summary (registry, in English)
This study is being done to observe the effects of treatment from a device called the Bioboosti which utilizes pulsed electromagnetic waves on its ability to improve blood flow to the heart tissue in individuals with coronary artery disease (CAD).
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 27 Oct 2021
- Start date
- 18 May 2022
- Primary completion date
- Jun 2027
- Lead sponsor
- Mayo Clinic
- Diseases
- Coronary artery disease
- NCT number
- NCT05111288
What you commit to
- Study type: Interventional
- Planned participants: 120
- From 18 May 2022 to the primary completion date, Jun 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe lung disease.
- Significant arrhythmia (ventricular tachycardia, ventricular fibrillation, frequent premature ventricular contractions (PVCs), persistent atrial fibrillation, or 2nd or 3rd degree atrioventricular (AV) block).
- Seizures.
- Unstable angina.
- Recent myocardial infarction (\< 90 days).
Lab values
- Anemia (\< 7 mg/dl).
- Low potassium (\< 3 mmol/L).
- Creatinine (\> 5.0 mg/dl or \< 0.6 mg/dl).
Other
- Unable to exercise due primarily to orthopedic limitation.
- Morbid obesity (BMI \> 42).
- Pregnant.
- Breast feeding.
- Coronary spasm.
- Recent percutaneous coronary intervention (\<90 days).
Who the study is looking for
- Age ≥ 18 years old.
- Known cardiac ischemia, who are non revascularizable, or have not and will not be undergo coronary intervention for the duration of their participation in the study.
- Evidence of ischemia from previous clinical tests (echo, nuclear, standard ECG from past 6 months).
- Left Ventricular Ejection fraction \> 40% by echo (evaluated last 3 months).
- Able to complete a cardiopulmonary exercise test without significant non cardiac limitations, primarily orthopedic.
- On guideline directed optimal therapy for stable ischemia.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic in Rochester Coordinator of this site? Confirm its status | Rochester | United States | Recruiting |
| Mayo Clinic in Arizona Coordinator of this site? Confirm its status | Scottsdale | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.